Click me to open the menu
Click me to close the menu

THCv - an abject cop-out from the ACMD, another research opportunity for the UK lost

24th January 2017

The ACMD has voted to keep THCv, a non-psychoactive cannabinoid with a promising properties for a range of health conditions, in Schedule 1 away from the hands of researchers.

Better late than never? After 82 years the WHO reviews cannabis!

22nd December 2016

The WHO has commissioned a cannabis review before the Commission for Narcotic Drugs 2018 meeting. This will be first WHO cannabis review since 1935!

Scheduling clash: revisiting ketamine (and legislation) harms

10th December 2013

Let’s get the War on Drugs out of our hospitals and laboratories

11th June 2013

The Dustbin of Schedule 1: How Schedule 1 control may stifle medical advances

23rd January 2013

Precaution or perversion: eight harms of the precautionary principle

23rd June 2010

  • DrugScience
  • 2 Langley Lane
  • London
  • SW8 1GB
  • info@drugscience.org.uk